Suppr超能文献

TYMS通过KEAP1-NRF2途径增强结肠直肠细胞抗氧化能力以抵抗铁死亡。

TYMS Enhances Colorectal Cell Antioxidant Capacity Via the KEAP1-NRF2 Pathway to Resist Ferroptosis.

作者信息

Chen Jingtian, Wu Wei, Wang Lingxiao, Zhang Jingjing, Che Xin, Zhai Liqin, Zhao Zhenxiang, Li Yaoping

机构信息

The Colorectal and Anal Surgery Department of Shanxi Provincial People's Hospital, Shanxi Medical University, Taiyuan, China.

Translational Medicine Research Center, Shanxi Medical University, Taiyuan, China.

出版信息

J Cancer. 2025 Jan 1;16(2):417-429. doi: 10.7150/jca.102931. eCollection 2025.

Abstract

Thymidylate synthase (TYMS) is a key regulatory enzyme in DNA synthesis. We identified the biological effect and molecular mechanisms of TYMS in colorectal cancer (CRC). We employed western blot and immunohistochemistry for the assessment of TYMS expression in CRC samples. MTT and colony assay were carried out to illuminate the effect of TYMS on the proliferation of CRC cells. Xenograft models were constructed to evaluate the consequences of TYMS overexpression on CRC . Metabolomics was utilized to analyze the alterations in cellular molecular metabolites subsequent to TYMS overexpression. The impact of TYMS on NRF2 localization and KEAP1 expression was explored by means of western blot. The expression levels of GSH, ROS, MDA, and mRNA were measured to assess ferroptosis. TYMS expression in CRC tumor tissues was upregulated compared to adjacent non-cancerous tissues. Cells overexpressing TYMS displayed enhanced proliferative capabilities. Metabolomic analysis revealed that overexpression of TYMS was associated with elevated levels of GSH within cells and a decrease in the lipid peroxidation product, 4-hydroxyhexenal. ROS detection assays further demonstrated a significant enhancement in cellular antioxidant capacity due to TYMS overexpression. Overexpression of TYMS downregulated KEAP1 expression and promoted NRF2 translocation into the nucleus. Consequently, transcription of downstream antioxidant genes was upregulated, enhancing cellular antioxidant capacity, reducing ROS levels, diminishing lipid peroxidation products, and heightening resistance to ferroptosis induced by erastin. Additionally, our study indicated that the TYMS inhibitor 5-fluorouracil (5-FU) exhibited favorable drug synergism with erastin. TYMS was overexpressed in CRC, which was correlated with poor prognosis of CRC patients. TYMS enhanced the antioxidant capacity of CRC cells via the KEAP1-NRF2 pathway, thereby increasing resistance to erastin-induced ferroptosis.

摘要

胸苷酸合成酶(TYMS)是DNA合成中的关键调节酶。我们确定了TYMS在结直肠癌(CRC)中的生物学效应和分子机制。我们采用蛋白质免疫印迹法和免疫组织化学法评估CRC样本中TYMS的表达。进行MTT和集落试验以阐明TYMS对CRC细胞增殖的影响。构建异种移植模型以评估TYMS过表达对CRC的影响。利用代谢组学分析TYMS过表达后细胞分子代谢物的变化。通过蛋白质免疫印迹法探究TYMS对NRF2定位和KEAP1表达的影响。测量谷胱甘肽(GSH)、活性氧(ROS)、丙二醛(MDA)和mRNA的表达水平以评估铁死亡。与相邻的非癌组织相比,CRC肿瘤组织中TYMS的表达上调。过表达TYMS的细胞表现出增强的增殖能力。代谢组学分析表明,TYMS过表达与细胞内GSH水平升高和脂质过氧化产物4-羟基己烯醛减少有关。ROS检测试验进一步证明,由于TYMS过表达,细胞抗氧化能力显著增强。TYMS过表达下调KEAP1表达并促进NRF2易位至细胞核。因此,下游抗氧化基因的转录上调,增强了细胞抗氧化能力,降低了ROS水平,减少了脂质过氧化产物,并提高了对erastin诱导的铁死亡的抗性。此外,我们的研究表明,TYMS抑制剂5-氟尿嘧啶(5-FU)与erastin表现出良好的药物协同作用。TYMS在CRC中过表达,这与CRC患者的不良预后相关。TYMS通过KEAP1-NRF2途径增强了CRC细胞的抗氧化能力,从而增加了对erastin诱导的铁死亡的抗性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b54/11685691/17abf14bfeef/jcav16p0417g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验